Endovasc files for angiogenesis stent patent
This article was originally published in Clinica
Endovasc has filed a patent application for a drug-coated stent designed to stimulate new blood vessel growth in blood-starved areas of the heart and limbs.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.